List of inhaled corticosteroids for asthma
Pro Research Analysisby 
Searched over 200M research papers
List of Inhaled Corticosteroids for Asthma
Introduction to Inhaled Corticosteroids (ICS) for Asthma
Inhaled corticosteroids (ICS) are the cornerstone of asthma management, effectively controlling symptoms and reducing inflammation in the airways. They are considered the first-line therapy for patients with persistent asthma, regardless of age or severity 26. ICS work by suppressing inflammation through the inhibition of multiple inflammatory pathways, thereby reducing airway hyperresponsiveness and preventing exacerbations .
Common Inhaled Corticosteroids
Fluticasone Propionate
Fluticasone propionate is a widely used ICS known for its efficacy in controlling asthma symptoms and improving lung function. Studies have shown that fluticasone, when compared to other ICS like beclomethasone and budesonide, has a less suppressive effect on growth in children, making it a preferred option in pediatric asthma management . Fluticasone is also effective in reducing asthma exacerbations and is often used in combination with long-acting beta2-agonists for enhanced control 57.
Budesonide
Budesonide is another commonly prescribed ICS that has been shown to improve clinical symptoms, lung function, and reduce airway inflammation in asthma patients . It is effective in both children and adults and is available in various delivery devices, such as the Easyhaler and Turbuhaler. Studies indicate that budesonide delivered via Easyhaler may have a less adverse effect on growth compared to the Turbuhaler .
Beclomethasone Dipropionate
Beclomethasone dipropionate is an ICS that has been used for many years in asthma management. It is effective in controlling asthma symptoms and improving lung function. However, when compared to fluticasone, beclomethasone may have a more significant impact on growth in children . Beclomethasone is available in different inhalation devices, including hydrofluoroalkane-metered dose inhalers (HFA-MDI) and chlorofluorocarbon-metered dose inhalers (CFC-MDI), with comparable efficacy .
Efficacy and Dose-Response Characteristics
The efficacy of ICS in asthma management is well-documented, with most benefits observed at low-to-moderate doses. High doses of ICS, such as fluticasone, may lead to small improvements in asthma control but are associated with an increased risk of oral side effects . For patients with severe asthma, high doses of ICS can help reduce the need for oral steroids .
Impact on Growth in Children
One of the concerns with long-term ICS use in children is the potential impact on growth. Studies have shown that different ICS molecules and delivery devices can have varying effects on linear growth velocity. Fluticasone, for instance, has been associated with a less suppressive effect on growth compared to beclomethasone and budesonide . However, the overall impact on growth is generally considered to be temporary and not progressive .
Conclusion
Inhaled corticosteroids are essential in the management of asthma, providing effective control of symptoms and prevention of exacerbations. Common ICS include fluticasone propionate, budesonide, and beclomethasone dipropionate, each with its own efficacy and safety profile. While concerns about growth suppression in children exist, the benefits of ICS in controlling asthma and improving quality of life outweigh these risks. Further research and personalized treatment approaches are necessary to optimize asthma management with ICS.
Sources and full results
Most relevant research papers on this topic
Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth.
Fluticasone may have a less suppressive effect on growth than budesonide, but no significant difference in linear growth velocity between fluticasone and budesonide.
Inhaled Corticosteroids for the Prevention of Asthma Exacerbations
Inhaled corticosteroids effectively prevent asthma exacerbations, with multiple dosing strategies reducing risk, allowing for personalized approaches based on individual patient phenotypes and preferences.
DOI